Biogen Inc. (BIIB): Price and Financial Metrics

Biogen Inc. (BIIB): $215.63

0.71 (-0.33%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add BIIB to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#75 of 365

in industry

BIIB Price/Volume Stats

Current price $215.63 52-week high $319.76
Prev. close $216.34 52-week low $211.01
Day low $214.00 Volume 1,912,200
Day high $217.57 Avg. volume 1,181,026
50-day MA $229.64 Dividend yield N/A
200-day MA $251.96 Market Cap 31.34B

BIIB Stock Price Chart Interactive Chart >

BIIB POWR Grades

  • BIIB scores best on the Sentiment dimension, with a Sentiment rank ahead of 88.74% of US stocks.
  • The strongest trend for BIIB is in Quality, which has been heading down over the past 26 weeks.
  • BIIB's current lowest rank is in the Growth metric (where it is better than 17.29% of US stocks).

BIIB Stock Summary

  • BIIB has a market capitalization of $38,170,509,644 -- more than approximately 93.25% of US stocks.
  • BIOGEN INC's stock had its IPO on September 17, 1991, making it an older stock than 83.59% of US equities in our set.
  • Price to trailing twelve month operating cash flow for BIIB is currently 28.07, higher than 84.95% of US stocks with positive operating cash flow.
  • Stocks with similar financial metrics, market capitalization, and price volatility to BIOGEN INC are ON, MCHP, GRMN, TER, and JNPR.
  • BIIB's SEC filings can be seen here. And to visit BIOGEN INC's official web site, go to www.biogen.com.

BIIB Valuation Summary

  • BIIB's price/sales ratio is 3.8; this is 9.52% lower than that of the median Healthcare stock.
  • Over the past 243 months, BIIB's price/sales ratio has gone down 8.8.

Below are key valuation metrics over time for BIIB.

Stock Date P/S P/B P/E EV/EBIT
BIIB 2023-12-29 3.8 2.6 25.7 26.7
BIIB 2023-12-28 3.8 2.6 25.8 26.8
BIIB 2023-12-27 3.8 2.6 26.0 27.0
BIIB 2023-12-26 3.8 2.6 25.8 26.9
BIIB 2023-12-22 3.7 2.6 25.6 26.6
BIIB 2023-12-21 3.7 2.5 25.2 26.2

BIIB Growth Metrics

    Its 5 year revenue growth rate is now at 25.06%.
  • The 4 year cash and equivalents growth rate now stands at 180.44%.
  • The year over year revenue growth rate now stands at -14.16%.
Over the past 15 months, BIIB's revenue has gone down $927,100,000.

The table below shows BIIB's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 10,173.4 1,384.3 3,046.9
2022-09-30 10,363.2 2,397.6 2,864.7
2022-06-30 10,633.6 2,541.9 2,059.2
2022-03-31 10,819.5 3,032.7 1,449.7
2021-12-31 10,981.7 3,639.9 1,556.1
2021-09-30 11,100.5 2,434.5 1,545.8

BIIB's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • BIIB has a Quality Grade of B, ranking ahead of 87.69% of graded US stocks.
  • BIIB's asset turnover comes in at 0.459 -- ranking 97th of 680 Pharmaceutical Products stocks.
  • ZSAN, ARMP, and HGEN are the stocks whose asset turnover ratios are most correlated with BIIB.

The table below shows BIIB's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.459 0.825 0.064
2021-06-30 0.478 0.839 0.098
2021-03-31 0.510 0.855 0.206
2020-12-31 0.531 0.866 0.283
2020-09-30 0.550 0.876 0.369
2020-06-30 0.545 0.880 0.415

BIIB Price Target

For more insight on analysts targets of BIIB, see our BIIB price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $417.00 Average Broker Recommendation 1.64 (Moderate Buy)

Biogen Inc. (BIIB) Company Bio


Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.(Source:Wikipedia)


BIIB Latest News Stream


Event/Time News Detail
Loading, please wait...

BIIB Latest Social Stream


Loading social stream, please wait...

View Full BIIB Social Stream

Latest BIIB News From Around the Web

Below are the latest news stories about BIOGEN INC that investors may wish to consider to help them evaluate BIIB as an investment opportunity.

12 Best Stocks to Buy for an 18 Year Old

In this article, we discuss the 12 best stocks to buy for an 18 year old. If you want to skip our detailed analysis of these stocks, go directly to 5 Best Stocks to Buy for an 18 Year Old. It is an exciting time to be involved in trading stocks. The Federal Reserve in […]

Yahoo | December 28, 2023

Healthcare Heroes: 3 Stocks Innovating in Medicine and Wellness

Discover these innovative healthcare stocks, backed by the U.S.'s $4.3 trillion health investment, offering stability and high returns.

Muslim Farooque on InvestorPlace | December 27, 2023

Top 3 Healthcare Stock Picks for the New Year

Buy these healthcare stocks for 2024 trading at bargain prices before their earnings inflect higher on improving fundamentals.

Charles Munyi on InvestorPlace | December 26, 2023

Ionis (IONS), AstraZeneca's Eplontersen Receives FDA Nod

FDA approves Ionis (IONS) and partner AstraZeneca's (AZN) Wainua for treating ATTRv-PN. Ionis stock rises on this important milestone.

Yahoo | December 22, 2023

Is Eli Lilly Stock A Buy Or A Sell As Shares Seesaw On Recent Obesity Drug Findings?

Is Eli Lilly stock a buy or a sell as shares seesaw in the wake of new Zepbound test results? LLY stock a buy or a sell right now?

Yahoo | December 20, 2023

Read More 'BIIB' Stories Here

BIIB Price Returns

1-mo -2.76%
3-mo -16.67%
6-mo -16.10%
1-year -21.63%
3-year -21.88%
5-year -8.78%
YTD -16.67%
2023 -6.55%
2022 15.42%
2021 -2.02%
2020 -17.48%
2019 -1.39%

Continue Researching BIIB

Want to see what other sources are saying about Biogen Inc's financials and stock price? Try the links below:

Biogen Inc (BIIB) Stock Price | Nasdaq
Biogen Inc (BIIB) Stock Quote, History and News - Yahoo Finance
Biogen Inc (BIIB) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!